Donna M. Shattuck-Eidens
Myriad Genetics
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Donna M. Shattuck-Eidens.
Journal of Clinical Oncology | 1998
Thomas S. Frank; Susan Manley; Olufunmilayo I. Olopade; Shelly Cummings; Judy Garber; Barbara Bernhardt; Karen H. Antman; Donna Russo; Marie Wood; Lisa Mullineau; Claudine Isaacs; Beth N. Peshkin; Saundra S. Buys; Vicki Venne; Peter T. Rowley; Starlene Loader; Kenneth Offit; Mark E. Robson; Heather Hampel; Dara Brener; Shelly Clark; Barbara L. Weber; Louise C. Strong; Paula T. Rieger; Melody McClure; Brian E. Ward; Donna M. Shattuck-Eidens; Arnold Oliphant; Mark H. Skolnick; Alun Thomas
PURPOSE Previous studies of mutations in BRCA1 or BRCA2 have used detection methods that may underestimate the actual frequency of mutations and have analyzed women using heterogeneous criteria for risk of hereditary cancer. PATIENTS AND METHODS A total of 238 women with breast cancer before age 50 or ovarian cancer at any age and at least one first- or second-degree relative with either diagnosis underwent sequence analysis of BRCA1 followed by analysis of BRCA2 (except for 27 women who declined analysis of BRCA2 after a deleterious mutation was discovered in BRCA1). Results were correlated with personal and family history of malignancy. RESULTS Deleterious mutations were identified in 94 (39%) women, including 59 of 117 (50%) from families with ovarian cancer and 35 of 121 (29%) from families without ovarian cancer. Mutations were identified in 14 of 70 (20%) women with just one other relative who developed breast cancer before age 50. In women with breast cancer, mutations in BRCA1 and BRCA2 were associated with a 10-fold increased risk of subsequent ovarian carcinoma (P = .005). CONCLUSION Because mutations in BRCA1 and BRCA2 in women with breast cancer are associated with an increased risk of ovarian cancer, analysis of these genes should be considered for women diagnosed with breast cancer who have a high probability of carrying a mutation according to the statistical model developed with these data.
Proceedings of the National Academy of Sciences of the United States of America | 2001
Susan B. Rivera; Bradley D. Swedlund; Gretchen J. King; Russell Bell; Charles Hussey; Donna M. Shattuck-Eidens; Wislawa M. Wrobel; Galen D. Peiser; C. Dale Poulter
Chrysanthemyl diphosphate synthase (CPPase) catalyzes the condensation of two molecules of dimethylallyl diphosphate to produce chrysanthemyl diphosphate (CPP), a monoterpene with a non-head-to-tail or irregular c1′-2-3 linkage between isoprenoid units. Irregular monoterpenes are common in Chrysanthemum cinerariaefolium and related members of the Asteraceae family. In C. cinerariaefolium, CPP is an intermediate in the biosynthesis of the pyrethrin ester insecticides. CPPase was purified from immature chrysanthemum flowers, and the N terminus of the protein was sequenced. A C. cinerariaefolium λ cDNA library was screened by using degenerate oligonucleotide probes based on the amino acid sequence to identify a CPPase clone that encoded a 45-kDa preprotein. The first 50 aa of the ORF constitute a putative plastidial targeting sequence. Recombinant CPPase bearing an N-terminal polyhistidine affinity tag in place of the targeting sequence was purified to homogeneity from an overproducing Escherichia coli strain by Ni2+ chromatography. Incubation of recombinant CPPase with dimethylallyl diphosphate produced CPP. The diphosphate ester was hydrolyzed by alkaline phosphatase, and the resulting monoterpene alcohol was analyzed by GC/MS to confirm its structure. The amino acid sequence of CPPase aligns closely with that of the chain elongation prenyltransferase farnesyl diphosphate synthase rather than squalene synthase or phytoene synthase, which catalyze c1′-2-3 cyclopropanation reactions similar to the CPPase reaction.
Mammalian Genome | 1995
Thomas Hattier; Russell Bell; Daniel Shaffer; Steven Stone; Robert Phelps; Sean V. Tavtigian; Mark H. Skolnick; Donna M. Shattuck-Eidens; Alexander Kamb
Positional cloning often requires isolation of candidate genes from a large, genetically defined region. Hybrid selection (direct cDNA selection, solution hybrid capture) is a rapid, simple procedure that has been used to identify expressed sequence tags (ESTs) from cloned genomic DNA. We used hybrid selection to screen a 600-kb region that includes the BRCA1 gene. From a set of 931 sequenced clones, we obtained 118 nonoverlapping candidate ESTs from ovary and lymphocyte cDNA. We analyzed the results of our hybrid selection experiments with particular attention to the overall completeness, efficiency, and background noise of the experiment. We introduce simple parameters that serve as measures of important aspects of the hybrid selection process in the context of positional cloning.
Science | 1994
Yoshio Miki; Jeff Swensen; Donna M. Shattuck-Eidens; P. Andrew Futreal; Keith D. Harshman; Sean V. Tavtigian; Qingyun Liu; Charles Cochran; L. Michelle Bennett; Wei Ding; Russell Bell; Judith Rosenthal; Charles Hussey; Thanh Tran; Melody McClure; Cheryl Frye; Tom Hattier; Robert Phelps; Astrid Haugen-Strano; Harold Katcher; Kazuko Yakumo; Zahra Gholami; Daniel Shaffer; Steven Stone; Steven Bayer; Christian Wray; Robert Bogden; Priya Dayananth; John H. Ward; Patricia N. Tonin
Science | 1994
P. Andrew Futreal; Qingyun Liu; Donna M. Shattuck-Eidens; Charles Cochran; Keith D. Harshman; Sean V. Tavtigian; L. Michelle Bennett; Astrid Haugen-Strano; Jeff Swensen; Yoshio Miki; Ken Eddington; Melody McClure; Cheryl Frye; Jane Weaver-Feldhaus; Wei Ding; Zahra Gholami; Peter Söderkvist; Lori A. Terry; Suresh C. Jhanwar; Andrew Berchuck; J. Dirk Iglehart; Jeffrey R. Marks; Dennis G. Ballinger; J. Cari Barrett; Mark H. Skolnick; Alexander Kamb; Roger W. Wiseman
Nature Genetics | 1994
Alexander Kamb; Donna M. Shattuck-Eidens; R. Eeles; Qingyun Liu; Nelleke A. Gruis; Wei Ding; Charles Hussey; Thanh Tran; Yoshio Miki; Jane Weaver-Feldhaus; Melody McClure; Joanne F. Aitken; David E. Anderson; Wilma Bergman; Rune R. Frants; David E. Goldgar; Adèle C. Green; Robert MacLennan; Nicholas G. Martin; Laurence J. Meyer; Youl P; John J. Zone; Mark H. Skolnick; Lisa A. Cannon-Albright
Nature Genetics | 1996
Sean V. Tavtigian; Jacques Simard; Johanna M. Rommens; Fergus J. Couch; Donna M. Shattuck-Eidens; Susan L. Neuhausen; Sofia D. Merajver; S. Thorlacius; Kenneth Offit; Dominique Stoppa-Lyonnet; Carole Bélanger; Russell Bell; Simin Berry; Robert Bogden; Qian Chen; Thaylon Davis; Martine Dumont; Cheryl Frye; Thomas Hattier; Srikanth Jammulapati; Teresa Janecki; Ping Jiang; Robert Kehrer; J. F. Leblanc; Jeff T. Mitchell; Jodi Mcarthur-Morrison; Kim Nguyen; Yi Peng; Carolle Samson; Marianne Schroeder
Nature Genetics | 1996
Fergus J. Couch; Linda M. Farid; Michelle L. DeShano; Sean V. Tavtigian; Kathleen A. Calzone; Lisa Campeau; Yi Peng; Bert Bogden; Qian Chen; Susan L. Neuhausen; Donna M. Shattuck-Eidens; Andrew K. Godwin; Mary B. Daly; Diane M. Radford; Scott Sedlacek; Johanna M. Rommens; Jacques Simard; Judy Garber; Sofia D. Merajver; Barbara L. Weber
Nature Genetics | 1994
Jacques Simard; Patricia N. Tonin; Francine Durocher; Kenneth Morgan; Johanna M. Rommens; S. Gingras; Carolle Samson; J. F. Leblanc; Carole Bélanger; F. Dion; Qingyun Liu; Mark H. Skolnick; David E. Goldgar; Donna M. Shattuck-Eidens; Fernand Labrie; Steven A. Narod
Nature Genetics | 1996
Susan L. Neuhausen; Teresa Gilewski; Larry Norton; Thao Tran; Peter McGuire; Jeff Swensen; Heather Hampel; Patrick I. Borgen; Karen T. Brown; Mark Skolnick; Donna M. Shattuck-Eidens; Suresh C. Jhanwar; David E. Goldgar; Kenneth Offit